Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Pharma Mar describes antitumor compounds from marine sponge

April 10, 1997

IntraBiotics initiates phase I trials of IB-367 for oral mucositis

April 10, 1997

Sugen receives patent coverage for GRB2 cancer target

April 9, 1997

NIH licenses PTC gene for cancer diagnosis and therapy

April 9, 1997

Nigella sativa plant extract exerts antiangiogenic activity

April 8, 1997

PEG-rHuMGDF safe and effective for chemotherapy-induced thrombocytopenia

April 8, 1997

Eagle licenses biotin technology from University of Washington

April 8, 1997

Taiho claims nitroimidazoles with antiangiogenic and contrast-enhancing effects

April 8, 1997

University of Texas/Regeneron research finding covered under U.S. patent

April 7, 1997

Onyx expands clinical trials of ONYX-015

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...